Gottlieb: Real Risk Of Congressional Action If Anti-Competitive Actions Continue
Executive Summary
To remain shielded from political forces that could change incentives, pharmaceutical industry must adopt 'a certain set of values,' US FDA Commissioner says.
You may also be interested in...
Gottlieb Tells Brand Firms To Sell Samples For Generics – Or Face The Consequences
The idea could help quiet growing criticism over system gaming and high drug prices.
Lyrica Generics Were Likely Delayed By A Pfizer Labeling Supplement
US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.
Lyrica Generics Likely Delayed By A Pfizer Labeling Supplement
US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.